問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberWA42293
Completed

2021-03-01 - 2023-07-30

Phase III

Terminated7

  • Sponsor

  • Trial scale

  • Update

    2026/02/01

Investigators and Locations

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Ping-Hung Kuo

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Liang-wen Hang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Tang-Hsiu Huang

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator Ming -Cheng Chan

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Principal Investigator 鄭世隆

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Terminated

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    15 participants

  • Global

    658 participants